- Janice Hopkins Tanne
- New York
The US president, Donald Trump, has promised to lower the cost of in vitro fertilisation (IVF) by urging companies that provide health insurance to their employees to offer the fertility treatment.
Trump—who has nicknamed himself the “fertilisation president”—hailed the move as one that would help lead to “many more beautiful American children.” However, despite the announcement being billed as the creation of a new “legal pathway” to offer IVF to more Americans—similar to options for dental or vision coverage1—there will be no requirement or support for companies to do so.
IVF has already been a focus of the Trump administration: during his election campaign Trump pledged to expand access. Then in February he signed an executive order to expand access to IVF, citing that campaign promise.2
The order directed Trump’s domestic policy chief to produce recommendations that would protect IVF access and …
